56 results
8-K/A
ASRT
Assertio Holdings Inc
12 Mar 24
Results of Operations and Financial Condition
5:01pm
to the Spectrum Merger and/or the recent approval and launch of generic indomethacin suppositories, antitrust litigation, opioid-related government
8-K
EX-99.1
ASRT
Assertio Holdings Inc
11 Mar 24
Assertio Reports Fourth Quarter and Full Year 2023 Financial Results
5:07pm
indomethacin suppositories, antitrust litigation, opioid-related government investigations, opioid-related litigation and related claims
8-K
EX-99
e1af4c
8 Nov 23
Assertio Reports Third Quarter 2023 Financial Results
4:03pm
8-K
EX-99.1
php7 wdt6advewk7m
3 Aug 23
Assertio Reports Second Quarter 2023 Financial Results, Closes Spectrum Acquisition
4:08pm
424B3
rk9i3f0
15 Jun 23
Prospectus supplement
4:23pm
425
xzcpvtjjnt2usj3g4p
9 May 23
Business combination disclosure
5:10pm
425
EX-99.1
de9jgy1a0ia0b85lsf
9 May 23
Business combination disclosure
7:16am
8-K
EX-99.1
9wa9jat
9 May 23
Assertio Reports First Quarter 2023 Financial Results, Raises Full Year 2023 Outlook
7:15am
425
va4xu9w
25 Apr 23
Business combination disclosure
4:39pm
8-K
yye4jtlt2ghvy
25 Apr 23
Regulation FD Disclosure
4:37pm
425
EX-99.1
xo5f st2x0cbkpq5
25 Apr 23
Business combination disclosure
9:28am
425
cjho0tab2atwdgu
25 Apr 23
Business combination disclosure
9:28am